EMEA-002079-PIP01-16-M01

Key facts

Active substance
Lumasiran (ALN-GO1)
Therapeutic area
Gastroentology-Hepatology
Decision number
P/0004/2020
PIP number
EMEA-002079-PIP01-16-M01
Pharmaceutical form(s)
Solution for injection
Condition(s) / indication(s)
Treatment of hyperoxaluria
Route(s) of administration
Subcutaneous use
Contact for public enquiries
Alnylam UK Limited
Tel. +1  8663300326
E-mail: clinicaltrials@alnylam.com
Decision type
PM: decision on the application for modification of an agreed PIP

Decision

How useful was this page?

Add your rating